Helicobacter Pylori Eradication in Functional Dyspepsia
Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
This study is designed to study benefit of eradicating Helicobacter Pylori in patients with
functional dyspepsia as compared to symptomatic treatment only. Helicobacter pylori positive
patients with Functional Dyspepsia will be divided into two study groups, one will receive
Helicobacter pylori eradication therapy and other will receive symptomatic treatment. Symptom
relief based on Likert scale will be compared in both groups.
Phase:
N/A
Details
Lead Sponsor:
Sir Ganga Ram Hospital
Treatments:
Amoxicillin Clarithromycin Pantoprazole Proton Pump Inhibitors Z 338